Lowell Farms Inc
Lowell Farms Inc. engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California. The company provides flowers, vape pens, oils, extracts, chocolate edibles, mints, gummies, topicals, tinctures, and pre-rolls under the House Weed, Moon, Original Pot Company, Cypress Cannabis, Humble Flowe… Read more
Lowell Farms Inc (LOWLF) - Net Assets
Latest net assets as of September 2024: $4.21 Million USD
Based on the latest financial reports, Lowell Farms Inc (LOWLF) has net assets worth $4.21 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($28.44 Million) and total liabilities ($24.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.21 Million |
| % of Total Assets | 14.79% |
| Annual Growth Rate | 335.11% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 284.22 |
Lowell Farms Inc - Net Assets Trend (2017–2022)
This chart illustrates how Lowell Farms Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lowell Farms Inc (2017–2022)
The table below shows the annual net assets of Lowell Farms Inc from 2017 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $48.12 Million | -31.56% |
| 2021-12-31 | $70.31 Million | +52.43% |
| 2020-12-31 | $46.12 Million | +89.34% |
| 2019-12-31 | $24.36 Million | +15511.62% |
| 2018-12-31 | $-158.06K | -611.80% |
| 2017-12-31 | $30.88K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lowell Farms Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13070800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $191.74 Million | 398.49% |
| Total Equity | $48.12 Million | 100.00% |
Lowell Farms Inc Competitors by Market Cap
The table below lists competitors of Lowell Farms Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TOKYO TATEMONO CO
MU:T6R
|
$199.01K |
|
elexxion AG
XETRA:E8X
|
$199.10K |
|
Nordea Inv EU SmCap Stars KL1
CO:NDIESCSKL1
|
$199.19K |
|
Wealth Invest Optimal Stabil
CO:WEIOS
|
$199.21K |
|
FERNHEIZWERK NEUK
BE:FHW
|
$198.79K |
|
Skychain Technologies Inc
PINK:SKTCF
|
$198.78K |
|
NEWPLATINUM
XBOT:NGPT-ETF
|
$198.71K |
|
Better Plant Sciences Inc
PINK:VEGGD
|
$198.71K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lowell Farms Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 70,307,000 to 48,117,000, a change of -22,190,000 (-31.6%).
- Net loss of 24,564,000 reduced equity.
- Other factors increased equity by 2,374,000.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-24.56 Million | -51.05% |
| Other Changes | $2.37 Million | +4.93% |
| Total Change | $- | -31.56% |
Book Value vs Market Value Analysis
This analysis compares Lowell Farms Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.03x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 20.62x to 0.03x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.00 | $0.01 | x |
| 2018-12-31 | $0.00 | $0.01 | x |
| 2019-12-31 | $0.74 | $0.01 | x |
| 2020-12-31 | $0.80 | $0.01 | x |
| 2021-12-31 | $0.70 | $0.01 | x |
| 2022-12-31 | $0.48 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lowell Farms Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -51.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -56.42%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 2.47x
- Recent ROE (-51.05%) is above the historical average (-140.32%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -530.91% | 0.00% | 0.00x | 20.39x | $-167.05K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-365.12K |
| 2019 | -208.34% | -137.00% | 0.54x | 2.84x | $-53.19 Million |
| 2020 | -16.51% | -17.87% | 0.38x | 2.44x | $-12.23 Million |
| 2021 | -35.10% | -45.93% | 0.39x | 1.95x | $-31.71 Million |
| 2022 | -51.05% | -56.42% | 0.37x | 2.47x | $-29.38 Million |
Industry Comparison
This section compares Lowell Farms Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lowell Farms Inc (LOWLF) | $4.21 Million | -530.91% | 5.76x | $198.86K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |